PMV Pharmaceuticals, Inc. is a precision oncology company, which is engaged in discovery and development of small molecule, tumor-agnostic therapies targeting p53. p53 is a tumor suppressor protein known as the guardian of the genome, and normal, or wild type, p53 has the ability to eliminate cancer cells. It is leveraging its precision oncology platform to develop a pipeline of orally available, potent and highly selective small molecule product candidates that target p53 mutations or other p53-related cancers. We show 19 historical shares outstanding datapoints in our coverage of PMVP's shares outstanding history.
Understanding the changing numbers of PMVP shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like PMVP versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching PMVP by allowing them to research PMVP shares outstanding history
as well as any other stock in our coverage universe. |
Free PMVP Email Alerts:
Video: Shares Outstanding Importance
